𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of cytomegalovirus pneumonitis with ganciclovir in renal transplantation

✍ Scribed by M. Stoffel; Y. Pirson; J. P. Squifflet; M. Lamy; P. Gianello; G. P. J. Alexandre

Publisher
Springer
Year
1988
Tongue
English
Weight
463 KB
Volume
1
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Detection of ganciclovir resistance afte
Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infection
✍ S. Alain; S. Hantz; C. Scieux; A. Karras; M.C. Mazeron; J.C. Szelag; B.M. Imbert πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 147 KB

## Abstract Whether valaciclovir (VCV) prophylaxis could be responsible for ganciclovir (GCV)‐resistance of __Human cytomegalovirus__ (HCMV) in transplantation has never been documented. A multicentric retrospective pilot study was undertaken to detect GCV‐resistance through mutations within the __

Simultaneous treatment of cytomegaloviru
Simultaneous treatment of cytomegalovirus and varicella zoster infections in a renal transplant recipient with ganciclovir: Use of viral load to monitor response to treatment
✍ Aitken, C.; Hawrami, K.; Miller, C.; Barrett Muir, W.; Yaqoob, M.; Breuer, J. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 2 views

Disseminated zoster occurring simultaneously with cytomegalovirus (CMV) disease in a renal transplant recipient is potentially life threatening. We describe the use of intravenous ganciclovir to treat both infections. The efficacy of treatment was assessed clinically and by the measurement of CMV vi

Treatment of cytomegalovirus pneumonitis
Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS
✍ C. Farthing; M. G. Anderson; M. E. Ellis; B. G. Gazzard; A. C. Chanas πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 319 KB

Foscarnet was administered to eight AIDS patients for suspected cytomegalovirus (CMV) pneumonitis as a continuous intravenous infusion for a minimum of 8 days. All the patients improved, three showing complete resolution of symptoms. Evidence of CMV infection from bronchoalveolar lavage samples was